DES MOINES, Iowa (AP) — A renewed and expanded effort from chemical giant Bayer to shield itself from lawsuits that claim its ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 activating mutations, one of the drugs central to the company’s plan to ...

Bayer is to buy UK-based KaNDy Therapeutics in a deal worth more than $800 million, adding the biotech’s menopause drug to its women’s health pipeline. Bayer will pay $425 million up front and ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Frankfurt, Germany, Nov. 11--Chemical and drug maker Bayer AG plans to spin off its industrial chemical division and part of its polymers division by early 2005 in an effort to strengthen its ...

The legislation permanently reclassifies fentanyl as a Schedule I drug, meaning it has no accepted medical use and a high potential for abuse. Other drugs with Schedule I classification ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The biotech industry’s DeepSeek moment came last fall.